RXi Pharmaceuticals (RXII) Added to the Russell Microcap Index
RXi Pharmaceuticals, a leader in the next generation of RNA targeting technology, announced that it has been added to the Russell Microcap Index as part of Russell Investments’ annual reconstitution of its family of U.S. indexes. Russell indexes are a commonly used tool among investment managers and institutional investors as a benchmark, helping to distinguish passive and active investments. The Russell indexes capture the 4,000 largest domestic stocks as of the end of May, ranking them by total market capitalization to create the Russell 3000 Index and the Russell Microcap Index. RXi Pharmaceutical’s new membership to the Russell Microcap Index…